
Lasagna-Reeves Lab
@lasagnalab
The lab of Cristian Lasagna-Reeves, Associate Professor at @bcmhouston Investigating cellular and molecular mechanisms of AD and other tauopathies
ID: 1208080401887121408
https://www.lasagnareeveslab.com/ 20-12-2019 17:44:02
246 Tweet
570 Followers
258 Following

The Rainwater Charitable Foundation has awarded Bess Frost the 2025 Rainwater Prize for Innovative Early-Career Scientist for groundbreaking work in neurodegenerative disorders related to tau, a hallmark protein associated with Alzheimer’s disease. Story: bit.ly/frostprize #BrownBrainScience🧠






Check out this innovative work by Wilfried Rossoll 👇👇👇 Clever approach combining expertise in proteomics and neuropathology made possible by CZI Science and The National Institute on Aging (NIA) …arneurodegeneration.biomedcentral.com/articles/10.11…

'A stress-dependent #TDP43 SUMOylation program preserves neuronal function' Terry R. Suk Terry R Suk Caroline E. Part, Jenny L. Zhang, Trina T. Nguyen...Maxime W. C. Rousseaux Maxime Rousseaux uOBMRI Université d'Ottawa | University of Ottawa #ALS …arneurodegeneration.biomedcentral.com/articles/10.11…


Great article featuring the pioneering work of Bess Frost science.org/content/articl…

We were proud to recognize our 2025 #RainwaterPrize winners, Dr. Kaj Blennow and Dr. Bess Frost, at #Tau2025. Thank you to everyone who helped celebrate their groundbreaking contributions to tauopathy research. Explore the impact of the prize.



SUMO to the rescue! Three new studies show that tagging TDP-43 with SUMO2/3 keeps it soluble under stress, preventing the toxic aggregates that mark ALS and FTD. Université d'Ottawa | University of Ottawa, @UNIMORE_Univ, Goethe-Universität ow.ly/ROwi50VQk61


🧠 Check out our new paper in Alzheimer's & Dementia Journals exploring how tau depletion improves vascular amyloid‐related deficits in a mouse model of CAA Thanks to Alzheimer's Association The Rainwater Charitable Foundation NIH Funding for supporting this work! alz-journals.onlinelibrary.wiley.com/doi/10.1002/al…


The FDA has cleared the first blood test to aid in diagnosis of Alzheimer’s. The test detects amyloid plaques, a hallmark of the disease, through a blood draw. “Today marks another important step in Alzheimer’s disease diagnosis,” said Maria C Carrillo PhD. “With today’s action by the





The Celeste Karch demonstrate that MAPT mRNA and tau protein are expressed in microglia in human brains and in hiPSC-derived #microglia like cells. 🧠 💡Learn more in their new molecularpsychiatry study: go.nature.com/447xVwS
